The role of oxidized phospholipids in atherosclerosis
Open Access
- 1 April 2009
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 50, S207-S212
- https://doi.org/10.1194/jlr.r800074-jlr200
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Dyslipidemia inhibits Toll-like receptor–induced activation of CD8α-negative dendritic cells and protective Th1 type immunityThe Journal of Experimental Medicine, 2007
- Vascular Endothelial Growth Factor Receptor 2 Plays a Role in the Activation of Aortic Endothelial Cells by Oxidized PhospholipidsArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Lipoprotein(a): A Unique Risk Factor for Cardiovascular DiseaseClinics in Laboratory Medicine, 2006
- Dyslipidemia Associated with Atherosclerotic Disease Systemically Alters Dendritic Cell MobilizationImmunity, 2004
- Epoxycyclopentenone-Containing Oxidized Phospholipids Restore Endothelial Barrier Function via Cdc42 and RacCirculation Research, 2004
- Specific Phospholipid Oxidation Products Inhibit Ligand Activation of Toll-Like Receptors 4 and 2Arteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Reduced Connexin43 Expression Inhibits Atherosclerotic Lesion Formation in Low-Density Lipoprotein Receptor–Deficient MiceCirculation, 2003
- Minimally Modified LDL Binds to CD14, Induces Macrophage Spreading via TLR4/MD-2, and Inhibits Phagocytosis of Apoptotic CellsOnline Journal of Public Health Informatics, 2003
- Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.JCI Insight, 1995
- Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.Proceedings of the National Academy of Sciences of the United States of America, 1992